Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.45% |
| 2 | Technology | 8.65% |
| 3 | Financials | 8.6% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UFS
801
DELISTED
DOMTAR CORPORATION (New)
UFS
| $21.2M | 0.03% |
553,369
+184,712
| +50% | +$6.84M |
|
802
Alliant Energy
LNT
$17.7B
| $21.1M | 0.03% |
385,063
-1,660,361
| -81% | -$88.2M |
|
803
Tractor Supply
TSCO
$18.4B
| $21.1M | 0.03% |
1,126,425
+433,000
| +62% | +$8.22M |
|
804
Live Nation Entertainment
LYV
$43.5B
| $21M | 0.03% |
293,626
-35,071
| -11% | -$2.38M |
|
|
BLUE
805
DELISTED
bluebird bio
BLUE
| $21M | 0.03% |
18,438
+12,954
| +236% | +$14.1M |
|
806
CALL
Viatris
VTRS
$19.2B
| $20.9M | 0.03% |
1,042,100
-432,900
| -29% | -$8.06M |
|
807
Globus Medical
GMED
$11.1B
| $20.9M | 0.03% |
355,667
+39,237
| +12% | +$2.13M |
|
|
CCC.WS
808
CALL
DELISTED
Clarivate Analytics Plc Warrants, each to purchase one Ordinary Share
CCC.WS
| $20.8M | 0.03% |
+1,240,000
| New | +$7.3M |
|
809
Leggett & Platt
LEG
$1.27B
| $20.8M | 0.03% |
409,150
+80,291
| +24% | +$3.94M |
|
810
CALL
Charles River Laboratories
CRL
$14.2B
| $20.6M | 0.03% |
+135,000
| New | +$18.7M |
|
811
Jones Lang LaSalle
JLL
$18.1B
| $20.6M | 0.03% |
118,462
-59,608
| -33% | -$9.37M |
|
|
GWPH
812
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $20.6M | 0.03% |
196,989
-656,778
| -77% | -$73.6M |
|
813
Nutanix
NTNX
$18B
| $20.6M | 0.03% |
658,802
-502,169
| -43% | -$14.8M |
|
814
PUT
Best Buy
BBY
$18B
| $20.6M | 0.03% |
234,300
+11,900
| +5% | +$911K |
|
815
iShares Core US Aggregate Bond ETF
AGG
$139B
| $20.6M | 0.03% |
183,001
+120,871
| +195% | +$13.6M |
|
816
Brighthouse Financial
BHF
$2.98B
| $20.5M | 0.03% |
523,166
+510,469
| +4,020% | +$20.1M |
|
817
J&J Snack Foods
JJSF
$1.67B
| $20.5M | 0.03% |
111,172
+29,764
| +37% | +$5.6M |
|
|
MLNX
818
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $20.5M | 0.03% |
174,800
+171,400
| +5,041% | +$19.5M |
|
819
CALL
MetLife
MET
$60.9B
| $20.4M | 0.03% |
400,900
-7,400
| -2% | -$357K |
|
820
O-I Glass
OI
$1.15B
| $20.4M | 0.03% |
1,710,030
-3,904,718
| -70% | -$39M |
|
821
CALL
Antero Resources
AR
$11.7B
| $20.4M | 0.03% |
7,157,600
| – | – |
|
|
GMHIU
822
DELISTED
Gores Metropoulos, Inc. Unit
GMHIU
| $20.4M | 0.03% |
1,920,000
| – | – |
|
823
Supernus Pharmaceuticals
SUPN
$2.64B
| $20.4M | 0.03% |
859,076
+361,525
| +73% | +$8.78M |
|
824
STAG Industrial
STAG
$7.15B
| $20.4M | 0.03% |
645,115
+520,284
| +417% | +$15.9M |
|
825
CALL
Boston Scientific
BSX
$72.3B
| $20.4M | 0.03% |
450,100
+97,700
| +28% | +$4.09M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.